Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Microbiol.

Sec. Infectious Agents and Disease

This article is part of the Research TopicInnovative Antibiofilm Strategies: Advancing the Management of Microbial Biofilm InfectionsView all 8 articles

ClpB affects biofilm formation in Methicillin-resistant Staphylococcus aureus

Provisionally accepted
Miao  YangMiao Yang1Shuang  WangShuang Wang1Qianwei  QuQianwei Qu2Hai  YangHai Yang3Xin  LiuXin Liu1Wei  PengWei Peng1*Yonghui  ZhouYonghui Zhou1*
  • 1Guizhou University of Traditional Chinese Medicine, Guiyang, China
  • 2Northeast Agricultural University, Harbin, China
  • 3The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, China

The final, formatted version of the article will be published soon.

Introduction: This study aims to explore the effects of the molecular chaperone ClpB on the biofilm formation and pathogenicity of methicillin-resistant Staphylococcus aureus (MRSA). Methods: The biological membrane formation was evaluated by constructing a clpB knockout strain (ΔclpB) and a complemented strain (CΔclpB) of USA300 MRSA, followed by crystal violet staining, scanning electron microscopy, confocal laser scanning microscopy, and quantitative analysis of extracellular matrix components. A mouse skin infection model was subsequently employed to assess wound healing, histopathological changes, and the expression levels of inflammatory factors. Results: The results showed that compared with the wild strain (WT), the biomass of ΔclpB biofilm was significantly reduced (p < 0.0001), the structure was damaged and the production of extracellular matrix (eDNA, polysaccharides, proteins) decreased. CΔclpB then returned to the WT level. In the in vivo experiments, the ΔclpB infection group had faster wound healing, reduced tissue damage, and decreased expressions of TNF-α and IL-6 at both protein and mRNA levels. Conclusion: ClpB promotes the formation of MRSA biofilms by regulating extracellular matrix synthesis and host inflammatory responses and is a potential target for anti-biofilm therapy.

Keywords: clpB, MRSA, Biofilm, Skin Infection, Extracellular Matrix

Received: 13 Oct 2025; Accepted: 21 Nov 2025.

Copyright: © 2025 Yang, Wang, Qu, Yang, Liu, Peng and Zhou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Wei Peng, 342732230@qq.com
Yonghui Zhou, zyhui@neau.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.